SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 16th, 2017 • Mateon Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 16th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of , 2017, between Mateon Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).